Pfizer buys Metsera in $10bn weight loss drug deal
Pfizer completes Metsera acquisition worth up to $10 billion, entering the competitive weight loss drug market. Learn how this deal positions Pfizer against Novo Nordisk.
Category : Search result: biotech
Nigerian Biotech Agencies Strengthen Safety Collaboration
Nigeria's biotechnology regulators strengthen collaboration to ensure safe genetic modification practices, promoting agricultural innovation and food security across the nation.
Novo Nordisk vs Pfizer: Bidding War for Obesity Drugmaker
Major pharmaceutical battle intensifies as Novo Nordisk challenges Pfizer in high-stakes acquisition race for obesity treatment specialist Metsera, reshaping the weight-loss drug market.
Page 1 of 1